FDA Announces Draft Guidance on Waivers of Signature Requirement for Clinical Trial Investigators

Summary

The Food and Drug Administration (FDA) has released a draft guidance document that partially revises its previous guidance on clinical trial investigators, explaining the agency's current thinking on waivers of the signature requirement for Form FDA 1572, a critical form used in clinical trials.